Hideki Kunichika

7PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 24, 2025
Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Kiyoyuki Minamiguchi, Mariko Irizato, Ryota Nakano

|May 16, 2025
Quantitative evaluation of tumor signal heterogeneity on gadoxetic acid-enhanced magnetic resonance imaging as a predictor of postoperative survival and antitumor immunity in hepatocellular carcinoma.

Shunsuke Doi, Satoshi Yasuda, Minako Nagai

|Jun 27, 2024
Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI.

Hideki Kunichika, Kiyoyuki Minamiguchi, Tetsuya Tachiiri

|May 11, 2024
Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma.

Tetsuya Tachiiri, Kiyoyuki Minamiguchi, Ryosuke Taiji

|Feb 10, 2024
Multimodality Imaging of Primary Hepatic Lymphoma: A Case Report and a Literature Review.

Ryosuke Taiji, Nagaaki Marugami, Aki Marugami

|May 26, 2023
Vascular Normalization Caused by Short-Term Lenvatinib Could Enhance Transarterial Chemoembolization in Hepatocellular Carcinoma.

Tetsuya Tachiiri, Hideyuki Nishiofuku, Shinsaku Maeda

Pageof 2

Frequent Collaborators

7 joint publications

Toshihiro Tanaka

5 joint publications

Ryosuke Taiji

4 joint publications

Tetsuya Tachiiri

3 joint publications

Satoshi Yamauchi